Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The First Clinical Study to Test Safety, Blood Levels and Other Effects of CDP6038 in Healthy Males

This study has been completed.
Information provided by (Responsible Party):
UCB Pharma Identifier:
First received: January 11, 2011
Last updated: March 21, 2012
Last verified: March 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2009
  Primary Completion Date: October 2009 (Final data collection date for primary outcome measure)